abstract |
A set of means for the treatment of a malignant pathology, an autoimmune disease or an infectious disease, comprising an effector cell which expresses the FcgammaRIII receptor (CD16) on its surface, and a monoclonal antibody, the affinity of the Fc region of said monoclonal antibody for CD16 being greater than the affinity of the Fc region of polyclonal immunoglobulins for CD16. |